IDNA Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Oct 28 at 5:09 PM ET (Korea 10/29 06:09)
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.47% | Return% 1Y | 70.46% | Total Holdings | 64 | Perf Week | 1.8% | Volume | 166,249 |
| Asset Type | Equities (Stocks) | AUM | $331M | Return% 3Y | 34.13% | NAV | $42.11 | Perf Month | 1.97% | Avg Volume | 0.14M |
| ETF Type | Global Equities | Dividend TTM | $0.28 (0.64%) | Return% 5Y | -2.21% | 52W High | 0.07% | Perf Quarter | 32.57% | Rel Volume | 1.22 |
| Active/Passive | Passive | Div Gr. 3/5Y | 31.32% 20.75% | Return% 10Y | - | 52W Low | 78.96% | Perf Half Y | 50.31% | Prev Close | $42.00 |
| IPO | 2019/6/13 | Flows% 1M | 13.56% | Return% SI | 8.21% | RSI (14) | 60.98 | Perf YTD | 65.98% | Price | $43.47 |
| Beta | 0.97 | Flows% 3M | 31.13% | Flows% YTD | 47.9% | Flows% 1Y | 47.11% | Perf Year | 71.43% | Volatility(W/M) | 3.15% 3.06% |
| SMA20 | 4.6% | SMA50 | 6.8% | SMA200 | 31.36% | ATR | 1.31 | ||||
iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
The top 10 make up 49% of the fund
TWST Twist Bioscience Corp 4.79% 4 
RVMD REVOLUTION MEDICINES, INC. 4.55% 5 
REGN REGENERON PHARMACEUTICALS, INC. 4.35% 6 
INCY INCYTE CORPORATION 4.23% 
MRNA MODERNA, INC. 4.19% 9 
TAK Takeda Pharmaceutical Company Limited 4.05% 10 
MRK MERCK & CO., INC. 3.91% Largest sectors first.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded about as much as usual. That is 122% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -13.4%. The S&P 500 did +69% over the same period.
Tap to view numbers
The price swings a lot
At its worst (September 2021) it fell 68% and has not fully recovered yet.
Tap to view numbers
The dividend is on the small side
Pays 0.64% annually in dividends.
Tap to view numbers
Money keeps flowing in
Over the past year, new money equal to 47.1% of assets came in.
Tap to view numbers
CURE Direxion Daily Healthcare Bull 3X ETF 184M 
RXL ProShares Ultra Health Care 2X Shares 106M 
XLVI State Street Health Care Select Sector SPDR Premium Income ETF 33M 
RXD-1× ProShares UltraShort Health Care -2x Shares 3M 
TBXU Direxion Daily Biotech Top 5 Bull 2X ETF 3M 
BBH VanEck Biotech ETF 0.35% 
MEDI Harbor Health Care ETF 0.8% 
GDOC Goldman Sachs Future Health Care Equity ETF 0.75% 
MEDX Horizon Kinetics Medical ETF 0.85% 
JDOC JPMorgan Healthcare Leaders ETF 0.65% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does IDNA have?
IDNA holds a total of 64 securities, with an AUM of approximately $331M.
Does IDNA pay dividends (distributions)?
IDNA's distribution yield is approximately 0.64%.
What is the 52-week high and low for IDNA?
IDNA has recorded a 52-week high of $43.44 and a low of $24.29.
